These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19298558)

  • 21. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does a Brugada pattern ECG precipitated by excessive-dose flecainide provide a diagnosis of a Brugada syndrome patient and/or contraindicate its use? A case study.
    Reiffel JA
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):e47-51. PubMed ID: 21846883
    [No Abstract]   [Full Text] [Related]  

  • 23. Best evidence topic report. Amiodarone or flecainide for cardioversion in acute onset atrial fibrillation.
    Argall J; Crawford I
    Emerg Med J; 2004 Mar; 21(2):199. PubMed ID: 14988348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tachycardia with wide QRS. Limitations of electrocardiographic criteria in patients treated with anti-arrhythmia agents].
    Le Davay M; Victor J; Dupuis JM; Merheb M; Tran P; Tadeï A
    Ann Cardiol Angeiol (Paris); 1994 May; 43(5):253-5. PubMed ID: 8074416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flecainide-induced myoclonus.
    Velasco SL; Sierra-Hidalgo F; Rodríguez RM; Guerreo AJ; Morales JR
    Clin Neuropharmacol; 2014; 37(2):65-6. PubMed ID: 24614665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flecainide.
    Ector H
    Acta Cardiol; 2011 Apr; 66(2):247-8. PubMed ID: 21591585
    [No Abstract]   [Full Text] [Related]  

  • 27. Termination of atrial fibrillation by flecainide: mechanistic insights from spectral analysis.
    Hunter RJ; Schilling RJ
    Europace; 2010 Apr; 12(4):453-4. PubMed ID: 20167613
    [No Abstract]   [Full Text] [Related]  

  • 28. Some patients with paroxysmal atrial fibrillation should carry flecainide or propafenone to self treat.
    Camm AJ; Savelieva I
    BMJ; 2007 Mar; 334(7594):637. PubMed ID: 17379911
    [No Abstract]   [Full Text] [Related]  

  • 29. Flecainide-induced myalgias and weakness: a rare adverse reaction.
    Kumar D; Rehman ME; Mersfelder T; Patel P
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33858882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bundle branch reentry tachycardia: a possible mechanism of flecainide proarrhythmia effect].
    Saoudi N; Berland J; Cribier A; Letac B
    Arch Mal Coeur Vaiss; 1988 Apr; 81(4):537-41. PubMed ID: 3136716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reduction of auricular fibrillation and tachycardia using intravenous flecainide].
    Cohen-Solal A; Juliard JM; Jaeger P; Farinotti P; Dahan M; Charlier P; Boujon B; Aumont MC
    Arch Mal Coeur Vaiss; 1987 Jul; 80(8):1290-6. PubMed ID: 3120666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation.
    Falk RH
    Ann Intern Med; 1989 Jul; 111(2):107-11. PubMed ID: 2500880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flecainide and propafenone induced ST-segment elevation in patients with atrial fibrillation: clue to specificity of Brugada-type electrocardiographic changes.
    Beldner S; Lin D; Marchlinski FE
    Am J Cardiol; 2004 Nov; 94(9):1184-5. PubMed ID: 15518618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The efficacy of oral treatment with flecainide for paroxysmal atrial fibrillation: correlation with plasma concentration].
    Villani GQ; Rosi A; Piepoli M; Gandolfini A; Groppi F; Groppi M; Arruzzoli S; Dieci G; Gazzola U
    G Ital Cardiol; 1990 Jun; 20(6):564-8. PubMed ID: 2121574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects].
    Alboni P; Botto GL; Baldi N
    Ital Heart J Suppl; 2005 Jun; 6(6):335-40. PubMed ID: 16013424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
    Brignole M; Menozzi C; Gasparini M; Bongiorni MG; Botto GL; Ometto R; Alboni P; Bruna C; Vincenti A; Verlato R;
    Eur Heart J; 2002 Jun; 23(11):892-900. PubMed ID: 12042011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the anti-arrhythmia effect of intravenous flecainide in supraventricular tachyarrhythmias].
    Garre L; Alvarez A; Cianciulli T; Quiroga J; Califano J; Mautner B
    Arch Inst Cardiol Mex; 1989; 59(3):241-4. PubMed ID: 2506843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of intravenous flecainide in the treatment of paroxysmal or recent-onset atrial fibrillations].
    Bolognesi R; Tsialtas D; Manca C; Visioli O
    Cardiologia; 1989 Feb; 34(2):173-6. PubMed ID: 2500238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A symposium: Supraventricular Arrhythmias: Update 1995. Boston, Massachusetts, May 6, 1995.
    Am J Cardiol; 1996 Jan; 77(3):1A-95A. PubMed ID: 8607386
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological cardioversion of recent onset atrial fibrillation.
    Khan IA
    Eur Heart J; 2004 Aug; 25(15):1274-6. PubMed ID: 15288151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.